Computex 2025 showed that innovation in PC hardware often involves sticking a screen on something but don't let that distract you from the genuine improvements underneath Look past the frivolous screens on the showfloor and you'll find some genuine upgrades headed our way. PC Gamer · May 28, 2025
I've seen every PC case that Computex has to offer and this new Havn chassis is my top pick thanks to its abnormally large fans, front grille and airflow optimisation I've seen heaps of new cases at Computex this past week but one PC case left a strong impression: Havn's BF 360. PC Gamer · May 27, 2025
Havn's Doom special edition PC case offers not one, but two sets of hollowed eye sockets to judge you while you game If it's not your own, give back the bone. PC Gamer · May 21, 2025
It's been a bumper year for PCs but my pick for the best new hardware in 2024 is a chassis, surprising even myself Flippin' brilliant. PC Gamer · Dec 24, 2024
Don't try and squeeze too many ideas inside one PC build: For this white gaming PC with an RTX 4080 Super, I very nearly did Follow along as I build a white gaming PC. PC Gamer · Nov 25, 2024
HAVN's new 'Unisheet' glass case is the totally panoramic PC you've been waiting for Unisheet Heatformed Glass for the win! PC Gamer · Jun 5, 2024
HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance Biotech psychedelics company HAVN Life Sciences Inc. (OTC: HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July 21, 2022. Benzinga · Aug 19, 2022
Mycotopia Therapies Expands Supply Agreement With HAVN Life Sciences To Include Functional Mushrooms & Other Products Mycotopia Therapies Inc. (OTC:TPIA) announced its plans to enter the $13 billion medicinal mushroom market with HAVN Life Sciences' biopharmaceuticals and Ei.Ventures MANA products. Benzinga · Mar 21, 2022
HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function, announced on Thursday its entry into an exclusive U.S. Benzinga · Feb 11, 2022